chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a RN concerning an 11 year old male with allergic rhinitis and allergies to Suprax, Amoxicillin and "ceft" who on 11/07/00 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live (Lot # 634843/1868J). It was unknown if there was an illness at vaccination.  There were no concomitant medications. It was noted that the child developed mild varicella on approximately 01/16/04.  Follow up information received from a RN indicated that on 01/03/04, the pt developed pox bumps to his general body after being vaccinated against varicella and post exposure to varicella. No other symptoms were noted. The duration was unknown. No treatment was ordered.  There were no relevant diagnostic tests or lab data. The outcome was reported as recovered. The reporter also indicated that 2 of the pt's siblings developed varicella after vaccination with varicella virus vaccine live (WAES # 0401USA01995 & WAES # 0402USA01298).  Further information is expected.
No additional adverse events reported; dose of PROQUAD was given today 06/18/2021 to a 21 year old patient instead ofMMRll; dose of PROQUAD was given today 06/18/2021 to a 21 yr old patient instead ofMMRll; This spontaneous report as received from a nurse refers to a 21-year-old female patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication. On 18-JUN-2021,  the patient was vaccinated with a dose measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) rHa, lot # T028138,0 .5 milliliter, subcutaneous for prophylaxis instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II). No treatment was given. The patient sought unspecified medical attention. No additional adverse events reported.
Sore arm first few hours, headache and slight fever next day, with large tender lump under right armpit.  The lump and tenderness lasted 7 days.
Left arm pain, numbness from elbow to entire hand, started about 2 week safer receiving Gardasil in that arm. Pain is intermittent and 5-10 in intensity. She dose have other symptoms of abdominal pain, and right arm pain, so it is unclear whether vaccine is a factor.
Received #2 Moderna on 3/5/2021. Started to not feel well the next day. By 3/9/2021, he was too sick to get out of bed. Friends stayed with him the previous night and opted to call 911 for hospital transport on 3/9.  He was admitted to a Medical Center and diagnosed with pneumonia. He died on 3/18/2021 in patient.
Pt. was seen in urgent care for a laceration to her knee on 7/8/06. She received a DTaP on 7/10/06 as she had not gotten her kindergarten immunizations. She presented to the clinic for an appointment with Dr. on 7/12/06 at 9:37 A.M. with a reddened, swollen, warm area on her right thigh surrounding the injection site area. There was no complaints of itching at the site. The MD observed a 3.0 cm erythematous, warm, raised area that was slightly tender. She did have adenopathy in the right groin area according to the MD. The symptoms were notice the previous evening by the patient's mother. She had inked a circle around the area and the MD noted the erythema was extending out beyond the circle when she saw her in the clinic. Temperature was normal. She was treated with Augmentin 400 mg bid for 10 days.
On 7/23/01, pt had rash on left arm and left foot. Seen in ER. No fever. He was given Benadryl by ER doctor. On 7/30/01, pt had a fine rash on his trunk and a fever. On 7/31/01, temperature normal. Rash on arm and foot is better today.
SOB worse with exertion for the last few days prior to admisson O2 sats 88% in ED on 2L, on 3L O2 (uses 2L O2 at home) fell 3 days prior to admission and hit head decadron started
Pt received 4 doses of Hepatitis B vax, 2 doses were /w Recombivax & 2 doses were /w Engerix B
Developed blisters on legs 4 days post-vaccination. Patient had high-grade fever (103F) on day 2 of rash. She developed cellulitis secondary to infected blister on her (L) leg. Placed on Clindamycin from the start. Developed smaller lesions on forehead started ZOVIRAX on day 4.
Patient was sitting in waiting area after vaccination. Ten minutes went by and he fainted. He was out for 1 minute or 2. His color was ashen and upon awakening he was nauseous , light- headed, shaky, with blurry vision. Bottled water we given to the patient. After 15 minutes he was able to get up and walk about without aid. He and his companion remained in the store for another 10 minutes and he was able to walk out on his own. I called the patient this morning and he is feeling much better, but felt bad last night.
This spontaneous report as received from a medical assistant refers to a patient (gender and age unknown). Approximately in 2011, the patient was vaccinated with the first dose of GARDASIL (lot# and expiration date unspecified by the reporter)(0.5ml, intramuscular, site unspecified)by another practice. On 25-JAN-2013, the patient was at the physician's office to receive the second dose of GARDASIL (lot# and expiration date unspecified by the reporter)(0.5ml, intramuscular, site unspecified). No other c0-suspects were reported. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
A two-month-old male patient received initial doses of Daptacel, lot number C2406AA, administered intra-muscularly in the right thigh, IPOL, lot number Y1050-2, administered subcutaneously in the left thigh, Comvax (manufacturer reported), lot number 00012F, administered intra-muscularly in the left thigh and Prevnar (manufacturer reported), lot number B086518, administered intra-muscularly in the right thigh on 20/Jun/2006. Four days later, the patient developed a rash on both legs below the knee. The patient recovered from this event. Follow-up information received on 28/Aug/2006 from a health care provider. The patient had no relevant diagnostic testings. He was not taking other medications. Additional medically relevant information was not provided.
Erythema overlying site of vaccination three days after the vaccination. No systemic illness. pain and erythema minor. (Left deltoid)
Patient under age 18 was vaccinated with Moderna, which is a vaccine error.  Troubleshooting: Scribe and vaccinator did not validate age;  screeners at the beginning of the process did not ask or turn her away on a Moderna-only day. An ID requirement has been put in place to prevent this situation from occurring in the future.  Follow up to be done by DCHHS Physician or delegee will include specific description of next steps for obtaining dose 2.
Systemic: Nausea-Mild, Systemic: Seizure-Mild, Systemic: Vomiting-Mild, Additional Details: After Janssen vaccine shot given to patient.Patient lowered her face and body to our blood machine monitor and appear to experienced partial seizure with mild symptoms. Called 911. Patient was assessed her side effects and she told them that she had history of epilepsy and haven't had an episode for at least a year. Provide water to her and also garbage bin next to her due to Patient being nausea. Paramedics arrived about 3 minutes after they were called.
Pt received her COVID vaccine 12/29, denies any initial reactions to vaccine, but over the past 5-6 days it is tender, deep joint pain, light red circular area surrounding the injection site, reports area only itches when it is touched but otherwise no, denies any fevers, n/v/d, headache
patient experienced 3 days now of trunck upper arms and neck with scattered 1-2 mm erythematous pustules that increase in numbers by about 10% per day.  he currently has about 20-30 count.  they do not itch, he has no fever or myalgias or other signs of adverse events. diagnosed by me today with erythema multiforme
This report describes arthritis in a female of unspeicified age who received Lyme disease vaccine recombinant OspA (Lymerix). It report was received from the vaccinee and had not been verified by a physician or other healthcare professional. The medical history, concurrent conditions  and concurrent medications were not specified. On an unspecified date, the vaccine received an injection of Lymerix; it was not known if she had received previous injections of Lymerix. The reporter stated that subsequent to her Lymerix vaccination she had "some' arthritis". As of 05/03/02, the outcome of the event was unknown. Additional information will not be available.
85 y/o male h/o poorly controlled COPD administered ZOSTAVAX in morning then by mid afternoon body aches, SOB, COPD exacerbation.
got flu, lasted 2 weeks; Initial information received on 18-Dec-2022 regarding an unsolicited valid Social Media non-serious case received  via consumer.  This case involves an unknown age and unknown gender patient who got flu, lasted 2 weeks after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer (dose, strength, frequency, formulation, route, batch number, expiry date: unknown) in unknown administration site.  On an unknown date the patient diagnosed with a non-serious got flu, lasted 2 weeks (influenza) (2 weeks latency) following the administration of influenza vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown
Weakness, nausea, headache, lack of appetite per staff. Symptoms were described by pt over phone not assessed by nurse.
Extremely tired; Extremely sleepy; Fever; Nauseous; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 14:30 (at the age of 43 years old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration in the left arm on 27Feb2021 at 13:00 as single dose for COVID-19 immunisation. The patient previously experienced allergies to food, medications, or other products which is unspecified. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extremely tired, extremely sleepy, fever and nauseous on 20Mar2021 at 12:00. The patient did not receive any treatment for the reported events. The clinical outcome of extremely tired, extremely sleepy, fever and nauseous was not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Initial report received from a healthcare professional on 17 September 2013. This is an invalid case as no patient identifiers were reported. A cluster of patients (5 patients) had received an intradermal dose of FLUZONE intradermal (batch number-UT4720AA, dose number in series and anatomical site of administration were not reported) on an unspecified date in September 2013. It was not reported if the patients had any illness at the time of vaccination and also the patient's pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. Concomitant medications were not reported. On an unspecified date in September 2013, after vaccination, the patients developed redness, 3-4 inch knot and pain at the injection site. Pain was reported to last a few to 5 days ans one of the patient had bad tasted in the mouth after vaccination. No laboratory investigations were done and corrective treatments were not reported. On an unspecified date, the patient had recovered from the events. List of Documents held by sender: None
3 hours after receiving the Pneumovax, site hard and reddened. Severe pain up all nite with pain. Saw MD 11/8/06 given antihistamine. Swelling and redness lasted 1 week. Pain lasted 3-4 days. 11/28/06 patient still complained of tingling in fingertips and tender spot at site.
Day of and next day: aches, soreness, fever is 99.1, and fatigue   Day 10: heat radiating off of arm at injection site. Swollen. Slightly itchy. The redness and swelling went down after a few hours.   Day 12: pink at injection site but edges spread. Still warm. Itching.
Hives and rash in the face around the cheeks, forehead and nose area. Felt light heart palpitations with Itchy throat, itchy eyes, lightheaded,  and headache.  This occurred an hour after the vaccine was administered.
Headache approximately 6 hours after vaccine.. identified it identical to the headache i had when I had covid 10/5/20. Woke up at 1am and head to toe body aches, hips, feet, back, knees...    Tylenol 500mg took at 838 am 1/7/20
Information has been received from a registered nurse referring to a female patient who was a nurse of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-NOV-2017, the nurse "got a splash" of the GARDASIL 9 in her eyes while administering GARDASIL 9 to an unspecified patient for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) involved. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1711USA003941.
I received the booster Friday at 2pm. Sunday Dec 26 around 8pm under my right eye started swelling, about 2 hours later my eyelid also. To the point that I could only partially open my eye. We went to get Benadryl, I took 2 tablets around midnight. At the same time my left eye started swelling also. 2 hours later both were still swelling. I took Benadryl every 4 hours. Around 9am Monday the swelling went down about 50%. During the day Monday I continued taking Benadryl. The swelling is still there, maybe at about 30% of what it was, mostly just in my right eye. Now it's Tuesday, I'm continuing the Benadryl but no improvement since yesterday. Still about 30% improvement. I haven't been able to see a doctor yet, as th  I haven't seen a doctor because they are fully booked. I don't want to go to Urgent Care or ER (unless it gets worse). I assume they would treat with prednisone, which I'm not sure should be mixed with the vaccine. So since I'd rather not take a steroid, I don't think they could do anything for me anyway. My doctor should be able to do a video conference in a few days. How can I find out what in the vaccine I would be allergic to? And what to do next time I need a booster. I'm nervous to take the vaccine again.
Dose administered after 30-day Use By Date or after manufacturer date of expiry; administer an expired vaccine to a patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 25-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Patient's allergies (medications, food and other products) reported as unknown. Patient COVID positive test or diagnosis reported as unknown.  Date the vial was initially stored in the refrigerator 23Apr2022.  No concomitant medication was reported.    No treatment information was reported.
not able to go to work; I can't feel better; bones hurt everyday, Doesn't go away; Fever; Chills; Feet pain; Muscle pain; Difficulty walking; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In August 2022, the patient received Shingles vaccine. In August 2022, less than a day after receiving Shingles vaccine, the patient experienced feeling unwell, bone pain, fever, chills, foot pain, muscle pain and walking difficulty. On an unknown date, the patient experienced inability to work. On an unknown date, the outcome of the feeling unwell, fever, chills, foot pain, muscle pain, walking difficulty and inability to work were unknown and the outcome of the bone pain was not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell, bone pain, fever, chills, foot pain, muscle pain, walking difficulty and inability to work to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 06-SEP-2022 and 12-SEP-2022 Reporter's Comment: The patient self-reported this case. The patient got Shingles vaccine one week ago from reporting date and could not felt better. Patient bone hurts every day. The patient stated she was doing just fine after being given the vaccine, but later at night the events started. Patient reported experiencing fever, chills, feet pain, muscle pain. Also, patient stated that got very sick and the bone pain did not go away. Patient reported experienced with Shingles vaccine because patient was healthy person and bones had never hurt before. The patient's doctor was not there at that time, so patient was treated by a nurse. Patient stated less than 2 weeks after vaccination, she had been not able to go to work. Patient had difficulty walking due to the feet pain. The reporter consented to follow up.
Patient had an appointment to receive her first COVID-19 vaccine. She was screened by Sound RFA, per policy, and one full dose (0.5 mL) of the Moderna vaccine was given.  It was subsequently discovered that the patient was only 17 years old, and therefore should not have received Moderna COVID-19 dose. Patient was monitored for 15 minutes, per policy. No adverse reaction occurred.  Clinical site supervisor was notified, patient and guardian were notified, and incident report was created and submitted.   This report is being completed due to the age recommendations.
Within minutes of the first dose of the Covid Vaccine, my daughter, passed out!  Her head fell between her legs! The mother lifted her what seemed to be lifeless body off the ground!  As I lifted her I realized she was unconscious, her lips were blue, her skin was grey, she was cold and she was unresponsive, but breathing!  After that episode which lasted about 3-5 minutes she came too a little and started to violently throw up and she informed me that she could not see!!!  As this was going on no one from the pharmacy came to our aid even though I was screaming call 911!  I called 911!  When the paramedics came they took her to ER where they ran tests and was monitored!
I had severe tightness in my chest and itchy eyes after receiving the vaccine. I was having respiratory chest pains and took a nebulizer. I had L2 to L3 fusion in July 2020. I had one or two blood tests but do not remember the dates. I have recovered respiratory wise.
My adverse event started on 11/28/2022 around 06:00PM. I had a sore throat. The next day I had fever, cough, runny nose and fatigue.  On the 4th day I had shortness of breath.  On 11/30/2022 I did a home COVID-19 test which was positive. I called my doctor on the same day she prescribed with me Paxlovid for 5 days.
Employee complained of left neck and left back burning pain, shortness of breath, tachycardia, face flushed, weak knees- felt like jello, pain in chest.
Autoinoculation angler of mouth occurring 24DEC10. No testing performed so probable autoinoculation of vaccine (smallpox vaccination).
Metallic taste; This is a spontaneous report from a contactable consumer (patient). A 32-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: El3247) via an unspecified route of administration, administered in arm right on 16Feb2021 12:30 PM as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history included IBS, enlarged mitro valve. The patient had known allergies to peanuts. Concomitant medications/other medications in two weeks included Benadryl. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: El1284) via an unspecified route of administration, administered in arm left on 26JanFeb2021 10:30 AM as DOSE 1, SINGLE for COVID-19 immunisation. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. On 19Feb2021 09:00 PM, the patient experienced metallic taste. The patient did not receive any treatment for the event. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information was expected.
Transient Blindness. A territory representative reported that a pt received an injection on Prevnar on 4/5/01. Approximately 3 hrs post vaccine the child developed a headache, sensitivity to light and couldn't see. He recovered about 1.5 hrs later that same day. Follow-up info received from the physician on 06/08/2001 indicated that the child was seen by the physician.
Fever 25JAN91, vomited, urticaria rash on arms & legs;
Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry; This spontaneous case was reported by a physical therapist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vial did not undergo any temperature excursions.  No treatment medication was reported by reporter.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up was received and included no significant information
OTHER ISSUE: I took the SPIKEVAX vaccine. I was reading about the SPIKEVAX vaccine and they have the following warning: "Vaccination with SPIKEVAX may not protect all people who receive the vaccine."   I contacted the company because I wanted to know how to tell if I was protected or not. I was told that they did not know and that information was not available.  Could you please tell me or direct me to someone that can answer my question? Your help will be greatly appreciated.d
Developed gout in right foot on 4/25. Treated with prednisone for three days and  symptoms have mostly resolved by 4/28.